Item 5. Other Information
2K characters. Original on sec.gov ·
Item 5. Other Information
(c) Trading Plans
During the 13-week period ended March 29, 2025, no directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934) of the Company adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as follows:
On February 28, 2025, Clifton Pemble, President and Chief Executive Officer, adopted a new written trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the potential sale of up to (i) 7,899 shares of our common shares, and (ii) 100% of the net shares (net of tax withholding) resulting from the maximum potential vesting of 53,464 gross shares of our common shares relating to equity awards during the plan period, subject to certain conditions. The first trade date will not occur until June 16, 2025 at the earliest, and the plan's maximum duration is until March 6, 2026.
On March 3, 2025, Douglas Boessen, Chief Financial Officer and Treasurer, adopted a new written trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the potential sale of up to (i) 2,338 shares of our common shares, and (ii) 100% of the net shares (net of tax withholding) resulting from the maximum potential vesting of 10,685 gross shares of our common shares relating to equity awards during the plan period, subject to certain conditions. The first trade date will not occur until June 9, 2025 at the earliest, and the plan's maximum duration is until March 4, 2026.